Neurogene (NGNE) Net Equity Issued and Repurchased (2014 - 2026)
Neurogene's Net Equity Issued and Repurchased was $22,000 in Q2 2026, down 67.6% from $68,000 a year earlier and down 89.1% from the prior quarter.
Powered by 
Analysis
Neurogene (NGNE) Net Equity Issued and Repurchased (2014 - 2026) Analysis & Trends
On a trailing twelve-month basis, Neurogene's Net Equity Issued and Repurchased was $30.52 million through Jun 30, 2026, down 83.8% year-over-year; for FY2025, it was $30.38 million, down 84.0% from FY2024.
- Net Equity Issued and Repurchased shows a five-year compound annual growth rate of -15.8% (FY2020 to FY2025).
- In earlier years, Net Equity Issued and Repurchased was $189.59 million in FY2024 (+105.3%), $92.34 million in FY2023 (+38.9%), $66.46 million in FY2022 and $411,000 in FY2021 (-99.4%).
- The Q2 2026 figure marks the lowest quarterly Net Equity Issued and Repurchased since Q1 2025.
- Compared with a year earlier, Net Equity Issued and Repurchased was higher in three of the last seven quarters, with growth averaging 147.6%.
- The best year-over-year quarter for Net Equity Issued and Repurchased over five years was Q1 2026 (growth of 957.9%); the worst was Q3 2021 (a decline of 100.0%).
- Per Business Quant data, NGNE's Net Equity Issued and Repurchased in the three quarters before Q2 2026 was $201,000 (Q1 2026), $20.58 million (Q4 2025) and $9.71 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 43.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 6.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 9.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 47.70 Mn |
| 10 | Neurogene | 627.40 Mn | 627.40 Mn | - | 22,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 22,000.00 |
| Mar 31, 2026 | 201,000.00 |
| Dec 31, 2025 | 20.58 Mn |
| Sep 30, 2025 | 9.71 Mn |
| Jun 30, 2025 | 68,000.00 |
| Mar 31, 2025 | 19,000.00 |
| Dec 31, 2024 | 188.40 Mn |
| Sep 30, 2024 | 143,000.00 |
| Jun 30, 2024 | 415,000.00 |
| Mar 31, 2024 | 629,000.00 |
| Dec 31, 2023 | 92.18 Mn |
| Sep 30, 2023 | 35,000.00 |
| Jun 30, 2023 | 20,000.00 |
| Mar 31, 2023 | 112,000.00 |
| Dec 31, 2022 | 66.33 Mn |
| Mar 31, 2022 | 134,000.00 |
| Dec 31, 2021 | 3,000.00 |
| Sep 30, 2021 | 32,000.00 |
| Jun 30, 2021 | 94,000.00 |
| Mar 31, 2021 | 282,000.00 |
API Access
Neurogene Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=NGNE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "NGNE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=NGNE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();